Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study.
暂无分享，去创建一个
A. Ravaud | R. Motzer | T. Choueiri | E. Plimack | J. Sosman | P. Sharma | U. Harmenberg | Y. Tomita | B. Escudier | J. Wagstaff | F. Donskov | D. McDermott | H. Gurney | S. George | H. Hammers | H. Hardy | P. Zalewski | M. Richardet | J. Doan | Huanyu Zhao